Navigation Links
Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients with Eosinophilic Esophagitis
Date:8/13/2012

SAN DIEGO, Aug. 13, 2012 /PRNewswire/ -- Meritage Pharma, Inc. announced today that it has initiated a Phase 2 clinical trial to evaluate oral budesonide suspension (OBS) for the treatment of adolescents and young adults with eosinophilic esophagitis (EoE), an allergic inflammatory condition of the esophagus. EoE is a chronic disease characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation. The trial is being conducted at multiple U.S. clinical centers that specialize in the treatment of patients with gastrointestinal diseases.

The double-blind, randomized, placebo-controlled 16-week study will enroll about 100 patients aged 12 to 25 with confirmed EoE and documented problems swallowing food. Patients will be evaluated after treatment of OBS or placebo by performing biopsies of the esophagus to assess eosinophilic infiltration. In addition, a symptom scoring tool will be used to evaluate patients' response to therapy. More information about the study may be found at www.clinicaltrials.gov, identifier NCT01642212.

Meritage's initial 12-week Phase 2 placebo-controlled dose-ranging trial evaluating 71 pediatric patients met the primary endpoint of reduction of esophageal eosinophilia and improvement in clinical symptom score. OBS was well tolerated with no serious adverse events.

EoE is an emerging disease that has been increasingly recognized by the medical community with a dramatic rise in its incidence and diagnosis over the last decade. The disease occurs when eosinophils, a type of white blood cell involved in allergic reactions, infiltrate the surface of the esophagus. This eosinophil infiltration le
'/>"/>

SOURCE Meritage Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cadence Pharmaceuticals To Present At The Wedbush PACGROW Life Sciences Management Access Conference In New York City On August 14, 2012
2. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
3. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
4. Intercept Pharmaceuticals Closes $30 Million Series C Financing
5. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
6. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
7. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
8. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
9. New Managed Markets E-Learning Courses From Pharmaceutical Institute Offer a Complete Public Payer Perspective
10. Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency
11. ViroPharma Incorporated Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015   Polymedco is committed to supporting ... CRC Awareness Month, we are offering all existing customers ... , Posters – to be hung in patient ... Patient Brochures with Stand – to be placed in ... to be put on/in patient charts as a reminder ...
(Date:3/2/2015)... VANCOUVER, British Columbia and ... DelMar Pharmaceuticals, Inc. (OTCQX: ... on developing and commercializing proven cancer therapies in ... received a Notice of Allowance from the U.S. ... number 13/817,096 entitled, " Compositions and methods to ...
(Date:3/2/2015)... 2015  Sarnova, parent company of Tri-anim Health ... www.tri-anim.com website, continuing Tri-anim,s mission to ... respiratory, anesthesia and other critical care supplies and ... site has many new features and enhanced functionality ... and ordering easier and more efficient for the ...
Breaking Medicine Technology:Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3
... TARRYTOWN, N.Y., Nov. 2, 2011 Siemens Healthcare Diagnostics ... a partnership aimed at setting new standards in ... of patients, infectious disease states and potential treatment paths. ... make existing Siemens molecular HIV tests compatible with the recently ...
... world leader in diabetes care, announced today that it has ... (DHF), a non-profit organization that raises diabetes awareness and connects ... of the Drive the Switch program, which has motivated more ... and their doctor about options for insulin delivery, like the ...
Cached Medicine Technology:New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing 2New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing 3Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 2Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 3Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 4Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 5Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 6Novo Nordisk Donates $50,000 to Diabetes Hands Foundation in Recognition of the Drive the Switch Program's Inaugural Year 7
(Date:3/2/2015)... 02, 2015 LegitScript, LLC, ... certification programs, including those for Internet pharmacy ... safety and classification, has launched a certification ... The new program, called iCareRx , ... regarding the identity of the owner/operator of ...
(Date:3/2/2015)... 2015 Atlantic Information Services, Inc. (AIS) ... Directory of Health Plans: 2015 , the all-new 12th ... U.S. health plan market, with enrollment data and contact ... , Available as a printed book containing the ... in quick-view tables and charts, as well as an ...
(Date:3/2/2015)... Regulatory Compliance Associates® Inc. (RCA), ... and technical consulting, announces Mr. Seyed Khorashahi has ... , Before joining RCA, Mr. Khorashahi had over ... all aspects of developing safety-critical medical devices. ... Regulatory Compliance Associates Inc., Baxter Healthcare, and Beckman ...
(Date:3/2/2015)... In light of the FDA's approved ... (rivaroxaban) tablets, Ford & Associates Nationwide Legal Services ... future users, but may come too late for individuals ... drug. The FDA has now included the term “thrombocytopenia,” ... Xarelto's label. The term “cytolytic hepatitis” has also been ...
(Date:3/2/2015)... Dhaka, Bangladesh (PRWEB) March 02, 2015 ... appointment of fire safety expert Mark Chubb to serve ... oversee fire safety operations and training in Bangladesh and ... Members source. , “Mark will ensure that the ... and fire safety programs for Bangladesh garment workers,” said ...
Breaking Medicine News(10 mins):Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 4Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2
... June 13 Digirad Corporation,(Nasdaq: DRAD ), ... services to physicians, offices, hospitals and imaging centers, ... presenting at CapStone,Investments, Second Annual Small-Cap Investor Conference ... Center in Milwaukee., Casner,s 30-minute presentation, including ...
... of $15 Million for recent disasters, WASHINGTON, June ... it moves forward with relief efforts for,the victims of ... From Kansas to West Virginia, the Red Cross is ... shelters and tens of,thousands of meals., Already, more ...
... disease sooner, when it,s more treatable , , FRIDAY, June 13 ... pancreatic cancer have been identified by U.S. researchers, who said ... a blood test to detect this type of cancer in ... "Our team identified, for the first time, protein changes associated ...
... Paris, France, Friday 13 June 2008: The TRAF1/C5 locus ... role in multiple autoimmune diseases including type 1 diabetes ... presented today at EULAR 2008, the Annual Congress of ... , TRAF1 (Tumour Necrosis Factor-receptor associated factor 1) and ...
... June 2008: Tocilizumab plus methotrexate showed significant clinical ... moderate to severe rheumatoid arthritis (RA), who had ... therapy, according to a new study presented today ... European League Against Rheumatism in Paris, France. Tocilizumab, ...
... to be Smoke-Free in 90 Days, HARRISBURG, Pa., ... law the Clean Indoor Air Act, which will protect,Pennsylvanians ... smoking in most public places, including restaurants,workplaces and a ... from the persistence of advocates and,legislators who refused to ...
Cached Medicine News:Health News:Digirad Corporation to Present at CapStone Small-Cap Investor Conference 2Health News:American Red Cross Issues Appeal for Disaster Relief Fund 2Health News:Pancreatic Cancer Biomarkers Found 2Health News:Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases 2Health News:30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 2Health News:Governor Rendell Signs Bill Restricting Smoking in Most Public Places in Pennsylvania 3
... Chart Manager information can be input ... are not limited to drop-down lists ... each person to document individually. Patient ... valuable data and communication. All this ...
AllMeds was the first specialty-specific Electronic Medical Record for Orthopaedics. Instead of trying to force a general-purpose EMR into your practice, AllMeds starts with clinical content from Ort...
... software It runs over hospital ... PAS systems and some items ... collects data at initial consultation, ... checks, operation, post-op checks, telephone ...
... such as prescription writing, referral letters, chart ... will be ,able to add more appointments ... staff., Based on the exam documentation created ... recommend the appropriate E&M ,code for the ...
Medicine Products: